Neuromuscular Disease: Cardiac Manifestations and Sudden Death Risk

Worawan Limipitikul, Chin Siang Ong, Gordon F. Tomaselli

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Cardiovascular complications of neuromuscular diseases disproportionately affect the cardiac conduction system. Cardiomyopathy and cardiac arrhythmias produce significant morbidity and mortality. Patients with neuromuscular diseases should be carefully and frequently evaluated for the presence of bradycardia, heart block, and tachyarrhythmias. Preemptive treatment with permanent pacemakers or implanted defibrillators is appropriate in patients with conduction system disease or who are at risk for ventricular arrhythmias.

Original languageEnglish (US)
Pages (from-to)731-747
Number of pages17
JournalCardiac Electrophysiology Clinics
Volume9
Issue number4
DOIs
StatePublished - Dec 1 2017
Externally publishedYes

Fingerprint

Neuromuscular Diseases
Sudden Cardiac Death
Cardiac Arrhythmias
Heart Block
Defibrillators
Bradycardia
Cardiomyopathies
Tachycardia
Morbidity
Mortality
Therapeutics

Keywords

  • Arrhythmia
  • Conduction block
  • Implantable cardioverter-defibrillator (ICD)
  • Muscular dystrophy
  • Pacemaker
  • Sudden death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Neuromuscular Disease : Cardiac Manifestations and Sudden Death Risk. / Limipitikul, Worawan; Ong, Chin Siang; Tomaselli, Gordon F.

In: Cardiac Electrophysiology Clinics, Vol. 9, No. 4, 01.12.2017, p. 731-747.

Research output: Contribution to journalReview article

Limipitikul, Worawan ; Ong, Chin Siang ; Tomaselli, Gordon F. / Neuromuscular Disease : Cardiac Manifestations and Sudden Death Risk. In: Cardiac Electrophysiology Clinics. 2017 ; Vol. 9, No. 4. pp. 731-747.
@article{05050b392c674cba94a2a1dd90f917cc,
title = "Neuromuscular Disease: Cardiac Manifestations and Sudden Death Risk",
abstract = "Cardiovascular complications of neuromuscular diseases disproportionately affect the cardiac conduction system. Cardiomyopathy and cardiac arrhythmias produce significant morbidity and mortality. Patients with neuromuscular diseases should be carefully and frequently evaluated for the presence of bradycardia, heart block, and tachyarrhythmias. Preemptive treatment with permanent pacemakers or implanted defibrillators is appropriate in patients with conduction system disease or who are at risk for ventricular arrhythmias.",
keywords = "Arrhythmia, Conduction block, Implantable cardioverter-defibrillator (ICD), Muscular dystrophy, Pacemaker, Sudden death",
author = "Worawan Limipitikul and Ong, {Chin Siang} and Tomaselli, {Gordon F.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1016/j.ccep.2017.07.013",
language = "English (US)",
volume = "9",
pages = "731--747",
journal = "Cardiac Electrophysiology Clinics",
issn = "1877-9182",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Neuromuscular Disease

T2 - Cardiac Manifestations and Sudden Death Risk

AU - Limipitikul, Worawan

AU - Ong, Chin Siang

AU - Tomaselli, Gordon F.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Cardiovascular complications of neuromuscular diseases disproportionately affect the cardiac conduction system. Cardiomyopathy and cardiac arrhythmias produce significant morbidity and mortality. Patients with neuromuscular diseases should be carefully and frequently evaluated for the presence of bradycardia, heart block, and tachyarrhythmias. Preemptive treatment with permanent pacemakers or implanted defibrillators is appropriate in patients with conduction system disease or who are at risk for ventricular arrhythmias.

AB - Cardiovascular complications of neuromuscular diseases disproportionately affect the cardiac conduction system. Cardiomyopathy and cardiac arrhythmias produce significant morbidity and mortality. Patients with neuromuscular diseases should be carefully and frequently evaluated for the presence of bradycardia, heart block, and tachyarrhythmias. Preemptive treatment with permanent pacemakers or implanted defibrillators is appropriate in patients with conduction system disease or who are at risk for ventricular arrhythmias.

KW - Arrhythmia

KW - Conduction block

KW - Implantable cardioverter-defibrillator (ICD)

KW - Muscular dystrophy

KW - Pacemaker

KW - Sudden death

UR - http://www.scopus.com/inward/record.url?scp=85034964236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034964236&partnerID=8YFLogxK

U2 - 10.1016/j.ccep.2017.07.013

DO - 10.1016/j.ccep.2017.07.013

M3 - Review article

C2 - 29173414

AN - SCOPUS:85034964236

VL - 9

SP - 731

EP - 747

JO - Cardiac Electrophysiology Clinics

JF - Cardiac Electrophysiology Clinics

SN - 1877-9182

IS - 4

ER -